Jason A. Amello
2023 - Candel Therapeutics
In 2023, Jason A. Amello earned a total compensation of $692K as Former Chief Financial Officer at Candel Therapeutics.
Compensation breakdown
| Option Awards | $89,577 |
|---|---|
| Salary | $466,045 |
| Stock Awards | $123,203 |
| Other | $13,200 |
| Total | $692,025 |
Amello received $466K in salary, accounting for 67% of the total pay in 2023.
Amello also received $89.6K in option awards, $123.2K in stock awards and $13.2K in other compensation.
Rankings
In 2023, Jason A. Amello's compensation ranked 1,620th out of 2,918 executives tracked by ExecPay. In other words, Amello earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,620 out of 2,918 | 45th |
Division Manufacturing | 949 out of 1,608 | 41st |
Major group Chemicals And Allied Products | 607 out of 901 | 33rd |
Industry group Drugs | 591 out of 864 | 32nd |
Industry Biological Products, Except Diagnostic Substances | 160 out of 211 | 24th |
Source: SEC filing on May 30, 2024.
Amello's colleagues
We found two more compensation records of executives who worked with Jason A. Amello at Candel Therapeutics in 2023.